BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 24454857)

  • 1. Deficient EBV-specific B- and T-cell response in patients with chronic fatigue syndrome.
    Loebel M; Strohschein K; Giannini C; Koelsch U; Bauer S; Doebis C; Thomas S; Unterwalder N; von Baehr V; Reinke P; Knops M; Hanitsch LG; Meisel C; Volk HD; Scheibenbogen C
    PLoS One; 2014; 9(1):e85387. PubMed ID: 24454857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray.
    Loebel M; Eckey M; Sotzny F; Hahn E; Bauer S; Grabowski P; Zerweck J; Holenya P; Hanitsch LG; Wittke K; Borchmann P; Rüffer JU; Hiepe F; Ruprecht K; Behrends U; Meindl C; Volk HD; Reimer U; Scheibenbogen C
    PLoS One; 2017; 12(6):e0179124. PubMed ID: 28604802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgM serum antibodies to Epstein-Barr virus are uniquely present in a subset of patients with the chronic fatigue syndrome.
    Lerner AM; Beqaj SH; Deeter RG; Fitzgerald JT
    In Vivo; 2004; 18(2):101-6. PubMed ID: 15113035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased T-cell responses to Epstein-Barr virus with high viral load in patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma.
    Morishima S; Nakamura S; Yamamoto K; Miyauchi H; Kagami Y; Kinoshita T; Onoda H; Yatabe Y; Ito M; Miyamura K; Nagai H; Moritani S; Sugiura I; Tsushita K; Mihara H; Ohbayashi K; Iba S; Emi N; Okamoto M; Iwata S; Kimura H; Kuzushima K; Morishima Y
    Leuk Lymphoma; 2015 Apr; 56(4):1072-8. PubMed ID: 24975317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous measurement of antibodies to Epstein-Barr virus, human herpesvirus 6, herpes simplex virus types 1 and 2, and 14 enteroviruses in chronic fatigue syndrome: is there evidence of activation of a nonspecific polyclonal immune response?
    Manian FA
    Clin Infect Dis; 1994 Sep; 19(3):448-53. PubMed ID: 7811864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases.
    Joncas JH; Wills A; Reece E; Fox Z
    Can Med Assoc J; 1981 Oct; 125(8):845-9. PubMed ID: 6272957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human peripheral blood and bone marrow Epstein-Barr virus-specific T-cell repertoire in latent infection reveals distinct memory T-cell subsets.
    Guerreiro M; Na IK; Letsch A; Haase D; Bauer S; Meisel C; Roemhild A; Reinke P; Volk HD; Scheibenbogen C
    Eur J Immunol; 2010 Jun; 40(6):1566-76. PubMed ID: 20232341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody to Epstein-Barr virus deoxyuridine triphosphate nucleotidohydrolase and deoxyribonucleotide polymerase in a chronic fatigue syndrome subset.
    Lerner AM; Ariza ME; Williams M; Jason L; Beqaj S; Fitzgerald JT; Lemeshow S; Glaser R
    PLoS One; 2012; 7(11):e47891. PubMed ID: 23155374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to valganciclovir in chronic fatigue syndrome patients with human herpesvirus 6 and Epstein-Barr virus IgG antibody titers.
    Watt T; Oberfoell S; Balise R; Lunn MR; Kar AK; Merrihew L; Bhangoo MS; Montoya JG
    J Med Virol; 2012 Dec; 84(12):1967-74. PubMed ID: 23080504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr Virus and the Origin of Myalgic Encephalomyelitis or Chronic Fatigue Syndrome.
    Ruiz-Pablos M; Paiva B; Montero-Mateo R; Garcia N; Zabaleta A
    Front Immunol; 2021; 12():656797. PubMed ID: 34867935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus (EBV) and the chronic fatigue syndrome: normal virus load in blood and normal immunologic reactivity in the EBV regression assay.
    Swanink CM; van der Meer JW; Vercoulen JH; Bleijenberg G; Fennis JF; Galama JM
    Clin Infect Dis; 1995 May; 20(5):1390-2. PubMed ID: 7620030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of variations in levels of Epstein-Barr Virus (EBV) antigen and adaptive immune response during chronic active EBV infection in children.
    Xing Y; Song HM; Wei M; Liu Y; Zhang YH; Gao L
    J Immunotoxicol; 2013; 10(4):387-92. PubMed ID: 23418935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological and virological investigation of the role of the herpesviruses EBV, CMV and HHV-6 in post-infective fatigue syndrome.
    Cameron B; Flamand L; Juwana H; Middeldorp J; Naing Z; Rawlinson W; Ablashi D; Lloyd A
    J Med Virol; 2010 Oct; 82(10):1684-8. PubMed ID: 20827765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.
    Tischer S; Dieks D; Sukdolak C; Bunse C; Figueiredo C; Immenschuh S; Borchers S; Stripecke R; Maecker-Kolhoff B; Blasczyk R; Eiz-Vesper B
    J Immunol Methods; 2014 Jun; 408():101-13. PubMed ID: 24877879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to Human Herpesviruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.
    Blomberg J; Rizwan M; Böhlin-Wiener A; Elfaitouri A; Julin P; Zachrisson O; Rosén A; Gottfries CG
    Front Immunol; 2019; 10():1946. PubMed ID: 31475007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus-specific CD8(+) T lymphocytes from diffuse large B cell lymphoma patients are functionally impaired.
    Cárdenas D; Vélez G; Orfao A; Herrera MV; Solano J; Olaya M; Uribe AM; Saavedra C; Duarte M; Rodríguez M; López M; Fiorentino S; Quijano S
    Clin Exp Immunol; 2015 Nov; 182(2):173-83. PubMed ID: 26174440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody responses to Epstein-Barr virus, human herpesvirus 6 and human herpesvirus 7 in patients with chronic fatigue syndrome.
    Sairenji T; Yamanishi K; Tachibana Y; Bertoni G; Kurata T
    Intervirology; 1995; 38(5):269-73. PubMed ID: 8724857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged illness after infectious mononucleosis is associated with altered immunity but not with increased viral load.
    Cameron B; Bharadwaj M; Burrows J; Fazou C; Wakefield D; Hickie I; Ffrench R; Khanna R; Lloyd A;
    J Infect Dis; 2006 Mar; 193(5):664-71. PubMed ID: 16453261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus (EBV) replicative gene expression in tumour cells of AIDS-related non-Hodgkin's lymphoma in relation to CD4 cell number and antibody titres to EBV.
    Brousset P; Drouet E; Schlaifer D; Icart J; Payen C; Meggetto F; Marchou B; Massip P; Delsol G
    AIDS; 1994 May; 8(5):583-90. PubMed ID: 7914731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic Epstein-Barr virus-related hepatitis in immunocompetent patients.
    Petrova M; Muhtarova M; Nikolova M; Magaev S; Taskov H; Nikolovska D; Krastev Z
    World J Gastroenterol; 2006 Sep; 12(35):5711-6. PubMed ID: 17007027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.